Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
HealthCare Global Enterprises
Watchlist
HCG: Emerging Centers Are Scaling Up Well
Equity Bottom-Up
331 Views
25 Jun 2024 03:02
Led by scale up and operating leverage, HCG's profitability is growing strong. At the current valuation, an investment in HCG has potential to generate 85%+ upside.
What is covered in the Full Insight:
Introduction
Q4FY24 Earnings Update
Digital Initiatives
Outlook
FY26 Projections and Valuation
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Loading
Trending Collections
More »
South Korea
Event-Driven
Japan
Equity Bottom-Up
Equity Derivatives
India
Philippines
China
Index Rebalance
Asia Event-Driven
Trending Insights
More »
Toyota Industries (6201 JP): Thoughts on Intrinsic Value
Foshan Haitian Flavouring & Food (3288 HK): Offering Details & Index Inclusion
Virgin Australia (VGN AU): Touch & Go for Index Inclusion
Kioxia IPO Lockup Expiry - US$6.7bn Release, with Shareholders Eager to Sell
MINISO (9896 HK)'s (Possible) TOP TOY Spin-Off Is Priced In
Top Unpaywalled Insights
More »
Bearishness Persist in Soybeans Despite Rebound Hopes
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
[IO Technicals 2025/23] Bearish Momentum Persists
VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
HCG: Strong Q3FY25 and Promoter Change Update
30 Mar 2025
Healthcare Global (HCG): Strong Q2FY25 Led by Operating Leverage
21 Dec 2024
HCG: Executing Well With Prudent Expansion
22 Sep 2024
HCG: FY25 and FY26 Set To Be Defining Years
27 Mar 2024
HCG: Scaling Up Well | On Track for a Solid FY25
15 Dec 2023
Healthcare Global Enterprises Ltd - Margins Still Below Industry Levels; ARPOB Improves
15 Nov 2023
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x